Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 219-909-0 | CAS number: 2568-90-3
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Acute Toxicity: oral
Administrative data
- Endpoint:
- acute toxicity: oral
- Type of information:
- experimental study
- Adequacy of study:
- other information
- Study period:
- 29. Aug 1968 - 09. Sep 1968
- Reliability:
- 2 (reliable with restrictions)
- Rationale for reliability incl. deficiencies:
- other: Acceptable, well-documented report which meets basic scientific principles.
Data source
Reference
- Reference Type:
- study report
- Title:
- Unnamed
- Year:
- 1 968
- Report date:
- 1968
Materials and methods
- Principles of method if other than guideline:
- BASF test: The study was conducted according to an internal BASF method which in principle is comparable to the OECD Guideline 401.
- GLP compliance:
- no
Test material
- Reference substance name:
- 1,1'-[methylenebis(oxy)]dibutane
- EC Number:
- 219-909-0
- EC Name:
- 1,1'-[methylenebis(oxy)]dibutane
- Cas Number:
- 2568-90-3
- Molecular formula:
- C9H20O2
- IUPAC Name:
- 1,1'-[methylenebis(oxy)]dibutane
- Details on test material:
- - Name of test material (as cited in study report): Butylal; Formaldehyddibutylacetal
- Physical state: liquid
- Analytical purity: 98-99 %
Constituent 1
Test animals
- Species:
- rat
- Strain:
- other: US-rats
- Sex:
- male/female
- Details on test animals or test system and environmental conditions:
- TEST ANIMALS
- Weight at study initiation: male: 188 g (mean); female: 158 g (mean)
Administration / exposure
- Route of administration:
- oral: gavage
- Vehicle:
- other: 30% aqueous emulsion in Traganth
- Details on oral exposure:
- VEHICLE
- Concentration in vehicle: 2, 20 and 30 %
- Doses:
- 200, 1600, 3200, 6400 ml/kg bw (168, 1344, 2688, 5376 mg/kg bw; conversion into mg/kg is based on the density d= 0.84 g/cm3 according to GESTIS database)
- No. of animals per sex per dose:
- 10
- Control animals:
- not specified
- Details on study design:
- - Duration of observation period following administration: 7 days
- Frequency of observations: daily
- Necropsy of survivors performed: yes
- Other examinations performed: clinical signs
Results and discussion
Effect levels
- Sex:
- male/female
- Dose descriptor:
- LD50
- Effect level:
- > 5 376 mg/kg bw
- Remarks on result:
- other: mg/kg bw; conversion into mg/kg is based on the density d= 0.84 g/cm3 according to GESTIS database
- Mortality:
- 5376 mg/kg bw: one male died within 24 h.
- Clinical signs:
- 5376 mg/kg bw:
5 min after application irregular respiration, masticatory movement, watery mouth discharge, high stepping gait, piloerection.
24 h post application irregular respiration, latero-abdominal position and apathy were observed.
2688 mg/kg bw: on the day of application same symptoms as higher dose group and 24 h post application irregular respiration were noted.
168 and 1344 mg/kg bw: intermittent respiration, squatting posture, masticatory movements. - Body weight:
- no data
- Gross pathology:
- Died animals:
1x increased nose secretion;
Lung: distended and blood filled;
Intragastric tract: atony with aqueous-mucous content;
Bladder: dilatation
Sacrificed animals:
5x bronchitis and bronchiectasis; 2x bronchial pneumonia; 4x intravesicular clot and moderate dilatation of the bladder.
Any other information on results incl. tables
Mortality:
Dose (mg/kg bw) | Gender | 1 h | 24 h | 48 h | 7 days | |||||
5376 | male | 0/10 | 1/10 | 1/10 | 1/10 | |||||
5376 | female | 0/10 | 0/10 | 0/10 | 0/10 | |||||
2608 | male | 0/10 | 0/10 | 0/10 | 0/10 | |||||
2608 | female | 0/10 | 0/10 | 0/10 | 0/10 | |||||
1344 | male | 0/10 | 0/10 | 0/10 | 0/10 | |||||
1344 | female | 0/10 | 0/10 | 0/10 | 0/10 | |||||
168 | male | 0/10 | 0/10 | 0/10 | 0/10 | |||||
168 | female | 0/10 | 0/10 | 0/10 | 0/10 |
The test substance caused signs of slight systemic toxicity after a single ingestion but mortality only in high doses.
Applicant's summary and conclusion
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.